GlucoTrack (NASDAQ:GCTK) Announces Earnings Results

Posted by Jeff Wilder on Apr 1st, 2026

GlucoTrack (NASDAQ:GCTK – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($3.98) earnings per share for the quarter, reports.

GlucoTrack Price Performance

GlucoTrack stock opened at $0.63 on Wednesday. The stock’s 50 day moving average is $1.70 and its 200 day moving average is $4.29. GlucoTrack has a one year low of $0.62 and a one year high of $15.90. The firm has a market cap of $632,260.00, a P/E ratio of -0.01 and a beta of 0.33. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.53 and a quick ratio of 1.53.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Bank of America Corp DE increased its holdings in GlucoTrack by 102,125.0% in the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC acquired a new position in shares of GlucoTrack during the 4th quarter valued at $52,000. Finally, Ikarian Capital LLC bought a new position in GlucoTrack during the fourth quarter worth $177,000. 10.92% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, GlucoTrack has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on GCTK

GlucoTrack Company Profile

(Get Free Report)

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.